Your browser doesn't support javascript.
loading
Matrix-Based Activity Pattern Classification as a Novel Method for the Characterization of Enzyme Inhibitors Derived from High-Throughput Screening.
Auld, Douglas S; Jimenez, Marta; Yue, Kimberley; Busby, Scott; Chen, Yu-Chi; Bowes, Scott; Wendel, Greg; Smith, Thomas; Zhang, Ji-Hu.
Afiliação
  • Auld DS; 1 Novartis Institutes for Biomedical Research, Center for Proteomic Chemistry, Cambridge, MA, USA.
  • Jimenez M; 1 Novartis Institutes for Biomedical Research, Center for Proteomic Chemistry, Cambridge, MA, USA.
  • Yue K; 1 Novartis Institutes for Biomedical Research, Center for Proteomic Chemistry, Cambridge, MA, USA.
  • Busby S; 1 Novartis Institutes for Biomedical Research, Center for Proteomic Chemistry, Cambridge, MA, USA.
  • Chen YC; 1 Novartis Institutes for Biomedical Research, Center for Proteomic Chemistry, Cambridge, MA, USA.
  • Bowes S; 2 National Center for Advancing Translational Sciences, Bethesda, MD, USA.
  • Wendel G; 1 Novartis Institutes for Biomedical Research, Center for Proteomic Chemistry, Cambridge, MA, USA.
  • Smith T; 1 Novartis Institutes for Biomedical Research, Center for Proteomic Chemistry, Cambridge, MA, USA.
  • Zhang JH; 1 Novartis Institutes for Biomedical Research, Center for Proteomic Chemistry, Cambridge, MA, USA.
J Biomol Screen ; 21(10): 1075-1089, 2016 Dec.
Article em En | MEDLINE | ID: mdl-27601436
ABSTRACT
One of the central questions in the characterization of enzyme inhibitors is determining the mode of inhibition (MOI). Classically, this is done with a number of low-throughput methods in which inhibition models are fitted to the data. The ability to rapidly characterize the MOI for inhibitors arising from high-throughput screening in which hundreds to thousands of primary inhibitors may need to be characterized would greatly help in lead selection efforts. Here we describe a novel method for determining the MOI of a compound without the need for curve fitting of the enzyme inhibition data. We provide experimental data to demonstrate the utility of this new high-throughput MOI classification method based on nonparametric analysis of the activity derived from a small matrix of substrate and inhibitor concentrations (e.g., from a 4S × 4I matrix). Lists of inhibitors from four different enzyme assays are studied, and the results are compared with the previously described IC50-shift method for MOI classification. The MOI results from this method are in good agreement with the known MOI and compare favorably with those from the IC50-shift method. In addition, we discuss some advantages and limitations of the method and provide recommendations for utilization of this MOI classification method.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores Enzimáticos / Enzimas / Ensaios de Triagem em Larga Escala Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores Enzimáticos / Enzimas / Ensaios de Triagem em Larga Escala Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article